Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 15Head & Neck 7Gastrointestinal 5Tumor-Agnostic 4Genitourinary 3Endocrine 3Breast 3Plasma cell 1Other solid neoplasm 1Gynecologic 1

Conditions

Neoplasms 2Adenocarcinoma 2Neoplasm Metastasis 1

Interventions

pembrolizumab 62Paclitaxel 51Gemcitabine 50Carboplatin 45Docetaxel 43Cisplatin 31Pemetrexed 30Nivolumab 28Bevacizumab 28atezolizumab 22Fluorouracil 22Cetuximab 21Capecitabine 21Irinotecan 20Leucovorin 19Afatinib 18Erlotinib Hydrochloride 15trametinib 14Trastuzumab 13Ipilimumab 13130-nm albumin-bound paclitaxel 13regorafenib 11olaparib 11Sorafenib 11Oxaliplatin 11Drug Therapy 11eribulin 10enzalutamide 10Midazolam 10Injections 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × vandetanib × Tumor-Agnostic × Clear all
NCT00500292 2018-01-25

A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer

Sanofi

Phase 2 Completed
109 enrolled 8 charts
Tumor-Agnostic

Neoplasms

NCT00503711 2016-08-31

Phase I Chinese PK

Sanofi

Phase 1 Completed
36 enrolled
Tumor-Agnostic

Neoplasms

NCT00499850 2016-08-25

Phase I FOLFOX Combination

Sanofi

Phase 1 Completed
18 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT00507091 2016-08-25

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Sanofi

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡